Index S&P 500
P/E 30.36
EPS (ttm) 2.53
Insider Own 0.30%
Shs Outstand 352.03M
Perf Week -0.82%
Market Cap 27.05B
Forward P/E 18.43
EPS next Y 4.17
Insider Trans -21.10%
Shs Float 350.96M
Perf Month -4.39%
Income 899.60M
PEG 3.10
EPS next Q 0.92
Inst Own 95.26%
Short Float 0.84%
Perf Quarter -8.97%
Sales 6.13B
P/S 4.41
EPS this Y 11.03%
Inst Trans -8.27%
Short Ratio 1.84
Perf Half Y 12.83%
Book/sh 29.76
P/B 2.58
EPS next Y 9.48%
ROA 5.40%
Short Interest 2.95M
Perf Year 16.95%
Cash/sh 2.00
P/C 38.39
EPS next 5Y 9.80%
ROE 8.84%
52W Range 63.05 - 87.10
Perf YTD 4.35%
Dividend Est. 0.32 (0.41%)
P/FCF 20.39
EPS past 5Y -21.58%
ROI 6.16%
52W High -11.79%
Beta 1.14
Dividend TTM 0.30 (0.39%)
Quick Ratio 1.14
Sales past 5Y 0.13%
Gross Margin 59.55%
52W Low 21.86%
ATR (14) 1.11
Dividend Ex-Date May 31, 2024
Current Ratio 1.47
EPS Y/Y TTM 18.77%
Oper. Margin 18.48%
RSI (14) 40.11
Volatility 1.00% 1.62%
Employees 18000
Debt/Eq 0.39
Sales Y/Y TTM 3.71%
Profit Margin 14.68%
Recom 2.05
Target Price 88.58
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q 19.63%
Payout 11.91%
Rel Volume 0.93
Prev Close 77.14
Sales Surprise -0.21%
EPS Surprise 4.09%
Sales Q/Q 4.37%
Earnings Apr 24 BMO
Avg Volume 1.61M
Price 76.83
SMA20 -0.05%
SMA50 -5.32%
SMA200 0.69%
Trades
Volume 800,024
Change -0.40%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Downgrade
JP Morgan
Overweight → Neutral
$95 → $90
Mar-14-24 Initiated
Truist
Buy
$99
Jan-02-24 Downgrade
Vertical Research
Buy → Hold
Oct-26-23 Downgrade
BofA Securities
Buy → Neutral
$70
Oct-05-23 Initiated
Exane BNP Paribas
Outperform
$91
Aug-07-23 Initiated
Seaport Research Partners
Buy
$92
Mar-27-23 Upgrade
Vertical Research
Hold → Buy
$74
Oct-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$68 → $73
Mar-17-22 Upgrade
Argus
Hold → Buy
$68
Mar-14-22 Upgrade
Barclays
Equal Weight → Overweight
$75
Jan-03-22 Downgrade
Vertical Research
Buy → Hold
$82
Dec-17-21 Initiated
Mizuho
Neutral
$82
Nov-23-21 Initiated
Loop Capital
Buy
$90
Oct-08-21 Initiated
Wells Fargo
Equal Weight
$72
Jul-12-21 Upgrade
Wolfe Research
Peer Perform → Outperform
May-20-21 Upgrade
JP Morgan
Neutral → Overweight
$70 → $80
Feb-17-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$75
Dec-08-20 Downgrade
Wolfe Research
Outperform → Peer Perform
$71 → $78
Dec-04-20 Initiated
UBS
Buy
$83
Nov-30-20 Downgrade
Barclays
Overweight → Equal Weight
$72
Show Previous Ratings
May-13-24 05:20PM
May-08-24 04:15PM
07:30AM
May-06-24 02:50PM
May-01-24 04:15PM
12:00PM
Loading…
12:00PM
Apr-26-24 08:52AM
Apr-25-24 01:01PM
01:04AM
Apr-24-24 06:38PM
(Morningstar Research) -5.76%
11:52AM
09:30AM
08:51AM
08:40AM
08:10AM
07:39AM
Loading…
07:39AM
(Associated Press Finance)
07:30AM
Apr-19-24 09:15AM
09:15AM
Apr-18-24 09:35AM
Apr-17-24 10:01AM
Apr-04-24 04:15PM
Mar-28-24 04:15PM
03:41AM
Mar-20-24 11:40AM
Mar-19-24 07:00AM
Mar-14-24 09:40AM
Mar-13-24 10:53AM
Mar-12-24 04:15PM
Mar-06-24 04:15PM
09:06AM
Loading…
Mar-04-24 09:06AM
Mar-01-24 11:30AM
Feb-29-24 09:40AM
Feb-28-24 12:04AM
Feb-09-24 04:15PM
04:15PM
Feb-08-24 05:27PM
Feb-03-24 12:01PM
Feb-02-24 09:55AM
Feb-01-24 06:54PM
(Morningstar Research) +5.18%
11:17AM
07:22AM
03:20AM
(Thomson Reuters StreetEvents)
Jan-31-24 06:14PM
09:30AM
08:40AM
07:50AM
(Associated Press Finance)
07:30AM
Jan-26-24 09:15AM
Jan-24-24 10:00AM
Jan-23-24 04:30PM
04:30PM
Jan-16-24 11:00AM
Jan-04-24 09:03AM
Jan-03-24 07:02AM
Dec-21-23 04:15PM
Dec-05-23 08:00AM
Nov-24-23 11:31AM
Nov-02-23 04:15PM
Oct-31-23 04:15PM
Oct-27-23 02:29PM
Oct-26-23 11:09AM
09:56AM
08:44AM
05:01AM
(Thomson Reuters StreetEvents)
Oct-25-23 10:17AM
09:48AM
07:51AM
(Associated Press Finance)
07:30AM
Oct-23-23 06:53AM
06:51AM
06:00AM
Oct-19-23 09:00AM
Oct-18-23 10:01AM
Oct-03-23 02:37PM
Sep-29-23 05:30PM
Sep-19-23 10:30AM
Sep-12-23 11:00AM
Aug-31-23 12:16PM
Aug-30-23 04:15PM
12:41PM
Aug-29-23 01:02PM
Aug-24-23 05:27PM
Aug-18-23 11:39AM
Aug-17-23 05:15PM
Aug-03-23 03:52PM
Jul-27-23 07:30AM
07:30AM
06:19AM
Jul-26-23 08:05PM
07:41AM
07:30AM
Jul-20-23 02:30PM
Jul-06-23 01:13PM
Jun-29-23 04:15PM
Jun-28-23 10:24AM
Jun-27-23 10:07AM
07:37AM
07:22AM
Jun-22-23 08:00AM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LICO JAMES A President and CEO May 15 '24 Option Exercise 30.42 29,480 896,782 500,894 May 16 07:37 PM Walker Stacey A. SVP - Human Resources Feb 29 '24 Sale 85.11 842 71,663 35,716 Mar 01 05:23 PM Walker Stacey A. SVP - Human Resources Feb 28 '24 Option Exercise 33.36 2,331 77,762 45,664 Mar 01 05:23 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '24 Sale 86.28 40,837 3,523,416 61,855 Mar 01 05:23 PM Walker Stacey A. SVP - Human Resources Feb 28 '24 Sale 86.50 9,106 787,669 36,558 Mar 01 05:23 PM Underwood Peter C SVP - General Counsel Feb 28 '24 Sale 86.39 5,000 431,950 47,138 Mar 01 05:23 PM Schwarz Jonathan L SVP - Corporate Development Feb 23 '24 Option Exercise 31.07 11,315 351,557 67,116 Feb 27 06:14 PM Newcombe Tamara S. President & CEO of AHS and PT Feb 16 '24 Sale 85.00 5,000 425,000 55,017 Feb 20 08:32 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Option Exercise 36.09 8,994 324,601 29,558 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Option Exercise 35.61 6,088 216,788 12,072 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Sale 82.17 8,994 739,037 20,564 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Sale 82.26 6,088 500,799 5,984 Feb 12 06:55 PM LICO JAMES A President and CEO Feb 06 '24 Option Exercise 30.61 106,525 3,260,982 546,473 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 06 '24 Sale 81.50 106,525 8,681,347 439,948 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 02 '24 Option Exercise 31.07 100,000 3,107,000 539,948 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 02 '24 Sale 82.30 100,000 8,230,000 439,948 Feb 06 06:40 PM LICO JAMES A President and CEO Jul 28 '23 Option Exercise 27.26 185,540 5,057,820 485,797 Jul 31 05:47 PM Murphy Patrick K President & CEO of AHS Jul 28 '23 Option Exercise 35.38 21,793 771,036 82,509 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 '23 Option Exercise 27.26 16,911 460,994 118,230 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Option Exercise 29.63 4,436 131,436 10,549 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Option Exercise 29.32 3,869 113,434 26,207 Jul 31 05:54 PM Murphy Patrick K President & CEO of AHS Jul 28 '23 Sale 76.50 21,793 1,667,164 60,716 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 '23 Sale 76.66 16,911 1,296,397 101,319 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Sale 76.85 4,700 361,195 21,507 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Sale 76.84 4,436 340,862 6,113 Jul 31 05:54 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite